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INTRODUCTION 
Jaundice is one of the most common problems in 
neonatal period which observed in 60% of term and 80% 
of preterm neonates.  
Jaundice is one of the most common clinical phenomena 
in neonatal period which leads to referral to a doctor and 
receiving diagnostic and therapeutic services.1 This 
jaundice usually develops from 2- 4 days after birth and 
improves after 1 -2 weeks of self-administration. Most 
neonatal jaundice are due to increased red blood cell 
destruction and decreased bilirubin excretion. In the baby 
jaundice is view when bilirubin reaches to above 5-7 
mg/dl.2,3  
Hyperbilirubinemia in most cases is improved without 
treatment and does not leave any side-effects. But in a 
group of patient’s jaundices is rising and requiring 
treatment and if no treatment occurs brain complications 
and Kernicterus develops.4 Phototherapy is one of the 
most commonly used therapies.5 Phototherapy is used to 
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ABSTRACT 
 
Background: Jaundice is one of the most common problems in neonatal period. In 60% of term and 80% of preterm 
neonates are seen during the first week of birth and most cases are physiologic. Hyperbilirubinemia is the most 
common cause of jaundice in newborns. Phototherapy is used to treat it, which seems to be safe. Some studies showed 
that thrombocytopenia is one of the side effects of phototherapy. The aim of this study was to investigate the 
relationship between thrombocytopenia and phototherapy in newborns.  
Methods: This is a descriptive study that has been done on 100 neonates with jaundice which requiring phototherapy. 
A blood sample was taken at the admission time, 24 hours late, end of the phototherapy and 48 hours after the end of 
phototherapy to measure the bilirubin and the number of platelets along with other necessary tests for the study of 
hyperbilirubinemia. Data collected by a checklist and analyzed by statistical methods in SPSS version 19.  
Results: Of all neonates, 55% were boy and 45% were girl with mean age of 8.86 days. The mean platelet count 
before phototherapy, 24 hours late, at the end of phototherapy, and 48 hours after phototherapy were 298170, 288540, 
282620 and 266310, respectively which was statistically significant during time.  
Conclusions: The results of this study showed that phototherapy can lead to a significant reduction in platelet count 
in newborns. Also, there wasn’t seen any case of thrombocytopenia following phototherapy in the present study.  
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treat hyperbilirubinemia in infants and it causes the 
bilirubin to move from the skin to the blood plasma and 
to be excreted. Phototherapy performed by conventional 
or fiber optic lamps in a hospital reduces neonatal 
jaundice in comparison with non-treatment.6  
For the effectiveness of phototherapy, the best distance is 
20-30 cm and maximum 50 cm.7 The best wavelength is 
420-470 nm which is 450 exclusives.8 Use of 
phototherapy though safe, is not free of side effects. The 
complications of phototherapy included skin rash, watery 
diarrhea, rise in temperature, dehydration, DNA damage, 
shivering, retinal damage, nasal obstruction due to eye 
banding, bronze baby syndrome and hypocalcemia.9  
Different methods are used for treating jaundice which 
included phototherapy, blood transfusion, drugs and IVIG 
that among them, phototherapy is widely used to treat 
unconjugated hyperbilirubinemia.3,4  
The jaundice that appears on 2-3 days after birth is 
usually physiological, but it can be in a more severe form. 
Non-hemolytic familial jaundice (Carpenter syndrome) 
and jaundice due to early begin breastfeeding usually 
begin at 2-3 days.  
In jaundice which appears after the third day and in the 
first week, we should consider bacterial sepsis or urinary 
infection. This jaundice can be caused by other infections 
such as syphilis, toxoplasmosis, CMV or Enterovirus.  
Jaundice caused by severe ECMO or vascular leak 
syndrome, especially in premature infants can occur on 
first day or later. Phototherapy starts in the newborn with 
bilirubin about 16-18 mg/dl and starts in premature 
infants with low rate. Thrombocytopenia has never been 
described as one of the complications of phototherapy in 
any pediatric standard textbooks.1  
However, knowing the effect of phototherapy on platelet 
count, reticulocyte count and white blood cell count is 
very important. Because reducing or increasing them as 
an index for the diagnosis of some diseases such as 
infections in newborns. Few studies have been conducted 
on the effect of phototherapy on blood elements, 
especially white blood cells. Since the lower platelet can 
also cause complications such as bleeding and brain 
damage and even death. This study aims to investigate 
the incidence of thrombocytopenia following 
phototherapy in hyperbilirubinemic neonates. 
METHODS 
Study design and follow-up patients  
This descriptive cross-sectional study was performed on 
100 healthy babies with jaundice which need to 
phototherapy in the Ardabil city Hospital. A blood 
sample was taken at admission, 24 hours before the end 
of phototherapy and 48 hours after phototherapy for 
measuring the bilirubin and platelet count along with 
other necessary tests for hyperbilirubinemia.  
Inclusion and exclusion criteria 
Infants with neonatal jaundice, term infants, birth weight 
between 2500-4000 g and newborns with normal 
examination were enrolled to the study. Neonates with 
stop breathing, hemolytic anemia, sepsis, congenital 
anomalies, ABO, need for transfusion, high direct 
bilirubin and metabolic disease were excluded from the 
study. 
Statistical analysis  
Data were analyzed by SPSS 19 using descriptive and 
analytical statistical methods. In all tests p<0.05 was 
considered significant.  
Consent form 
Before study, the parents of the neonates completed the 
informed consent and then participated in the study. 
RESULTS 
A total of 100 neonates were enrolled in the study. Of all 
infants, 55% were boys and 45% were girls. Of all 
neonates, 69% had platelet loss after phototherapy of 
which 42 were boys and 27 were female but no evidence 
of thrombocytopenia was observed. There was no 
significant relationship between sex and platelet loss.  
 
Figure 1: Mean of platelet count by duration of 
phototherapy. 
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The average age of infants who had platelet loss 
following phototherapy was 6.38±3.13 days and other 
infants were 6.33±2.48 days and the difference wasn’t 
significant. The average birth weight of infants who had 
platelet loss after phototherapy was 3.26±4.29 kg and 
other were 3.4±0.38 kg and. The average total bilirubin 
for infants who had platelet loss following phototherapy 
was 16.58±2.2 mg / dl and others were 18.09±2.40 mg / 
dL and the difference wasn’t significant. The average 
bilirubin direct of neonates who had platelet loss 
following phototherapy was 0.62±0.6 mg / dl and others 
was 0.60±0.05 mg / dl and the difference wasn’t 
significant.  
The average duration of phototherapy in neonates with 
platelet loss after phototherapy was 0.9±0.86 days and 
others was 1.3±0.6 days and there was a significant 
difference between two groups. The average gestational 
age of neonates with platelet loss after phototherapy was 
38.6±2.27 weeks and others was 38.8±1.55 weeks and the 
difference wasn’t significant. The average platelet count 
of infants was 298170±77167 in admission time and 24 
hours after phototherapy this average reached to 
288540±84695 and these changes were statistically 
significant over time (Figure 1). Compare the changes in 
mean of platelet counts between times showed that all 
changes were significant between times. The higher mean 
was seen in the admission time and the least was in the 
end of phototherapy (Table 1). 
Table 1:  Compare the changes of platelet counts 
during time. 
Mean of platelet count Mean±SD p-value 
Admission time 77167±298170  
0.008 
24 hours late 84695 ±288540  
24 hours late 84695 ±288540  
0.017 
End of phototherapy 282620±90171 
End of phototherapy 282620±90171 
0.001 48 hours after end of 
phototherapy 
296310±78679 
To determine the incidence of platelet loss following 
phototherapy in Hyperbilirubinemic neonates by a 
severity of jaundice, total bilirubin was selected 17.01 as 
an index that babies with higher bilirubin were 
considered as severe jaundice and babies with lower 
bilirubin were considered as mild jaundice. 58% of 
newborns had severe jaundice and 42% had mild jaundice 
and of 69 neonates who had platelet loss, 39 had severe 
and 30 had mild jaundice and out of a total of 31 neonates 
who did not have platelet loss, 19 had severe and 12 had 
mild jaundice. There was no significant relationship 
between jaundice severity and platelet loss. 
DISCUSSION 
As seen Platelet loss following phototherapy was found 
to be relatively common in this study. Of the 100 
neonates who were included in the study, 69% had 
platelet loss following the start of phototherapy of these 
61% were boys and 37% were girls and this platelet loss 
was in normal range and any cases of thrombocytopenia 
observed in this study. Also, the total platelet count in 
patients at 0, 24 hours after the end of phototherapy and 
48 hours after phototherapy were 298170, 288540, 
282620, 296310 respectively.  
As seen by considering the average of initial platelet 
count as the control group, platelet levels decreased at 24 
hours and end of phototherapy and was lower than the 
initial level that most of it occur in the end of 
phototherapy and also by considering the average platelet 
at 48 hours after the completion of phototherapy at the 
same level as the primary level, it can be resulted that 
these significant changes were due to phototherapy. Also, 
there was a significant relationship between duration of 
phototherapy and platelet loss (P= 0.02).  
But there was no statistically significant relationship 
between the platelet loss of patients after phototherapy 
with sex, age, birth weight, gestational age, total and 
direct bilirubin level, severity of jaundice and parity.  
According to the data it can be assured to the parents that 
despite the fact that phototherapy may reduce the level of 
the primary platelet in the baby, this reduction is not 
limited to requiring special treatment and limiting the life 
of the baby. In the study of Khera et al, the platelet level 
of patients was measured at admission time and 24 hours 
after phototherapy and 48 after the end of phototherapy.  
35% of neonates had thrombocytopenia of them 74% had 
mild thrombocytopenia. In this paper phototherapy has 
been introduced as one of the reasons for 
thrombocytopenia that the best reduction in platelet count 
was in the first 24 hours after phototherapy but there was 
no significant correlation between age, sex, duration of 
phototherapy, gestational age, severity of jaundice, birth 
weight with thrombocytopenia.10  
In the present study, there were no cases of 
thrombocytopenia in 100 newborns with physiologic citer 
and 69 newborns had platelet loss compared to baseline. 
Also, there was a significant relationship between 
duration of phototherapy and platelet loss.  
But there was no significant relationship between age, 
sex, gestational age, severity of jaundice, birth weight 
and platelet loss. In the study of Pishva et al colleagues, 
of 101 neonates suffered from jaundice, 50 neonates 
(49.5%) were suffering from thrombocytopenia after 
phototherapy. Reduced platelet count during the first 24 
hours of phototherapy was observed.  
In the present study thrombocytopenia was not observed 
but platelet loss was observed in normal range and the 
rate of platelet loss at the end of phototherapy was more 
than the first 24 hours of phototherapy.11 In the study of 
Shahyan et al, on the second day, 40.2% of newborns had 
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platelet increase and 50.98% had platelet decrease. There 
was no significant relationship between sex, age, weight 
and bilirubin levels with decreasing platelet count. But 
there was a significant relationship between phototherapy 
duration and reducing platelet count that in our study of 
there was no significant relationship between sex, age, 
weight and bilirubin rate with decreasing platelet count 
but there was a significant relationship between 
phototherapy duration and reducing platelet count.12  
In the study of Ghaffarpour et al, there was a significant 
increase in platelet count after phototherapy but the 
changes in reticulocyte and lymphocyte and neutrophil 
were not meaningful. In our study, unlike the above study 
there was a decrease in the number of platelets not an 
increase in its number and the study was not conducted 
for other blood types.13 In the study of Lucey et al, it was 
found that there was no relation between gestational age 
and thrombocytopenia after phototherapy which was in 
line with the results of our study.14  
In the study of Sakha et al, leukocytes increased during 
phototherapy and the increase in white blood cells had 
significant relation with age and due to limitations, the 
number of white blood cells in newborns was not 
checked. In this study, the average platelet count of 
patients 48 hours after the phototherapy was similar to 
that of the primary platelet count and the resulting 
changes can be due to phototherapy.15 
CONCLUSION  
The results of this study showed that phototherapy only 
reduced the number of platelets in normal range but did 
not require thrombocytopenia in neonates. Also, there 
was a significant relationship between the duration of 
phototherapy and platelet loss and there was no 
significant relationship between birth weight, sex, age, 
nullipar or multiple pregnancy, gestational age and 
platelet count.  
Also, we could say that the changes in the number of 
platelets based on the average platelet count 48 hours 
after the completion of phototherapy, have been due to 
phototherapy. It is suggested that another study be 
conducted to investigate platelets on a daily for register 
platelet changes and check the relationship between 
phototherapy and other blood types. 
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